Category:

Health

Latest

UK to roll out life-saving COVID-19 treatment which was given to Donald Trump

“Ronapreve is the first dedicated medicine developed for COVID-19 to receive marketing authorisation from the MHRA (Medicines and Healthcare products Regulatory Agency), representing a significant milestone in how the NHS is able to fight this disease,” said Paul McManus, COVID-19 Lead at Roche Products Ltd.

“Together with Regeneron, we’re grateful for the collaboration of the vaccine taskforce and NHS England in helping to bring this important antibody cocktail to treat and prevent acute COVID-19 across the UK,” he said.

Struggling economies, widening inequality and millions vulnerable: the urgent need for vaccine equity

Inequitable vaccine distribution is not only leaving millions or billions of people vulnerable to the deadly virus, it is also allowing even more deadly variants to emerge and spread across the globe.

Moreover, an unequal distribution of vaccines will deepen inequality and exaggerate the gap between rich and poor and will reverse decades of hard-won progress on human development.
WHO has set a global target of 70 per cent of the population of all countries to be vaccinated by mid-2022, but to reach this goal a more equitable access to vaccines will be needed.Research suggests that enough vaccines will be produced in 2021 to cover 70 per cent of the global population of 7.8 billion. More than 4.6 million people have died from the virus since it swept across the globe from the beginning of 2020, but it’s expected that the rate of people dying will slow if more people are vaccinated.

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.